Elutia (ELUT) Other Non Operating Income (2020 - 2026)
Elutia (ELUT) reported Other Non Operating Income of $71000.0 for Q1 2026, up 167.62% on a YoY basis from $26530.2 in Q1 2025, and up 105.86% sequentially from -$1.2 million in Q4 2025.
Elutia (ELUT) Other Non Operating Income (2020 - 2026) Analysis & Trends
Elutia (ELUT) has 7 years of Other Non Operating Income data on file, last reported at $71000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 167.62% year-over-year to $71000.0; the trailing twelve-month figure through Mar 2026 stood at -$4.0 million (down 1000.0% YoY), and the FY2025 full-year result was -$2.8 million, down 332.55% from the prior year.
- Other Non Operating Income climbed to $71000.0 in Q1 2026, from -$1.2 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $5.0 million in Q4 2022 to a low of -$1.4 million in Q2 2025.
- A 5-year average of $45363.6 and a median of -$257000.0 in 2024 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income sank 461.09% in 2025 and soared 167.62% in 2026, its largest moves.
- Tracing ELUT's Other Non Operating Income over 5 years: stood at $5.0 million in 2022, then plunged by 100.02% to -$1000.0 in 2023, then sank by 25600.0% to -$257000.0 in 2024, then plunged by 371.21% to -$1.2 million in 2025, then surged by 105.86% to $71000.0 in 2026.
- Business Quant data shows ELUT's Other Non Operating Income at $71000.0 in Q1 2026, -$1.2 million in Q4 2025, and -$1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71,000.00 |
| Dec 31, 2025 | -1.21 Mn |
| Sep 30, 2025 | -1.40 Mn |
| Jun 30, 2025 | -1.44 Mn |
| Mar 31, 2025 | -105,000.00 |
| Jun 30, 2024 | -257,000.00 |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | -758,000.00 |
| Dec 31, 2022 | 4.96 Mn |
| Sep 30, 2022 | -803,000.00 |
| Jun 30, 2021 | 3.58 Mn |
| Sep 30, 2020 | -2.57 Mn |